№ lp_2_3_44741
File format: docx
Character count: 27998
File size: 149 KB
Scientific medical report presenting the development and international consensus process of a universal structured form for documenting neuroblastoma surgical procedures and associated outcomes across pediatric oncology cooperative groups.
Type:
Original Report
Initiative:
Joint initiative by SIOPEN, COG and GPOH
Subject:
Standardized reporting of neuroblastoma surgery
Authors:
Lucas E. Matthyssens et al.
Affiliated Organizations:
SIOP Europe International Neuroblastoma Study Group (SIOPEN); Children’s Oncology Group (COG); Gesellschaft fuer Paediatrische Onkologie und Haematologie (GPOH)
Institutions:
Multiple pediatric surgical and oncology centers in Belgium, USA, The Netherlands, United Kingdom, Norway, France, Sweden, Italy, Spain and Germany
Corresponding Author:
Dr Lucas E. Matthyssens
Presentation:
50th Congress of the International Society of Pediatric Oncology (SIOP) and the International Society for Pediatric Surgical Oncology (IPSO), November 16, 2018, Kyoto, Japan
Conflicts of Interest:
None declared
Funding:
No funding received
Keywords:
Neuroblastoma; surgery; biopsy; resection; tumor; standardization; reporting; postoperative complication; outcome; Clavien-Dindo Classification
Scope:
International consensus on structured documentation of neuroblastoma-related surgical procedures and outcomes
Target Field:
Pediatric surgical oncology
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Note:
Year
Contextual description:
A research paper providing advanced imaging analysis methods for refining risk assessment in high-risk neuroblastoma patients.
Document Type:
Category 1 submission for Authority Required (Written) listing
Medicine:
Eflornithine (Ifinwil®) 250 mg tablet
Active Ingredient:
Eflornithine (as hydrochloride)
Sponsor:
Norgine Pty Ltd
Regulatory Authority:
Therapeutic Goods Administration (TGA)
Advisory Body:
Pharmaceutical Benefits Advisory Committee (PBAC)
Program:
Section 100 – Highly Specialised Drugs Program
Schedule:
General Schedule (Code GE – Schedule 85)
Indication:
High-risk neuroblastoma in patients aged 1 year and older in remission after prior therapy
Population:
Patients ≥1 year with high-risk neuroblastoma meeting INRG, COG, or SIOPEN criteria
Treatment Phase:
Initial and Continuing Treatment
Comparator:
Standard of care (follow-up and monitoring)
Clinical Outcomes:
Event-free survival, overall survival, safety
Dosage Form:
250 mg oral tablet
Treatment Duration:
Up to 27 cycles (2 years) or until disease progression
Orphan Drug Designation:
Granted 7 December 2022
Submission Pathway:
TGA/PBAC Parallel Process
Restriction Type:
Authority Required (Full assessment – written)
Prescriber Type:
Medical Practitioners (paediatric oncologist or haematologist for initiation)
Date:
April 22nd, 2025
Region / City:
Paris, France
Subject:
Immuno-oncology, Biotechnology
Document Type:
Press Release
Organization / Institution:
Egle Therapeutics
Author:
Egle Therapeutics
Target Audience:
Medical and scientific professionals in immuno-oncology and biotechnology
Period of Activity:
2025
Date of Approval:
April 22nd, 2025
Date of Changes:
N/A
Year:
2025
Region / city:
Scotland
Subject:
Food safety, food additives, feed additives, novel foods, genetically modified organisms
Document type:
Consultation
Organization:
Food Standards Scotland
Author:
Food Standards Scotland
Target audience:
Scottish food and feed businesses, local and district councils, and other stakeholders with an interest in food and feed safety
Period of validity:
From 8th January 2025 to 5th March 2025
Approval date:
8th January 2025
Date of amendments:
N/A
Research Theme:
Microbiology; Synthetic biology
PhD Research Project Title:
Genome-guided discovery of novel microbial enzymes and natural products
Scholarship category:
SBS Research Student Scholarship
Principal Investigator:
Liang Zhao-Xun
Co-supervisor/Collaborator:
NA
Proposed work:
Microbial genomics, Bioinformatics, Enzyme discovery, Functional characterization, Genetic manipulation, Synthetic biology
Preferred skills:
Basic understanding of biochemistry and molecular cloning
Application contact:
[email protected]
Application portal:
https://venus.wis.ntu.edu.sg/GOAL/OnlineApplicationModule/frmOnlineApplication.ASPX
Note:
Year
Year:
2021
Region / city:
N/A
Document type:
Research supplementary materials
Organization / institution:
University of North Carolina
Author:
Ling Xie, Ryan N. Sheehy, Yan Xiong, Adil Muneer, John A. Wrobel, Kwang-Su Park, Julia Velez, Jing Liu, Yan-Jia Luo, Ya-Dong Li, Luis Quintanilla, Yongyi Li, Chongchong Xu, Mohanish Deshmukh, Zhexing Wen, Jian Jin, Juan Song, Xian Chen
Target audience:
Researchers in neuroscience, pharmacology, and precision medicine
Period of validity:
N/A
Approval date:
N/A
Date of amendments:
N/A
Year:
1843
Region / City:
London
Theme:
Poverty, Social Issues, Christmas
Document Type:
Novel
Author:
Charles Dickens
Target Audience:
General public
Period of Effect:
19th century
Approval Date:
1843
Date of Changes:
N/A
Year:
2026
Region / City:
Global
Topic:
Antimalarial drug discovery, Plasmodium falciparum
Document Type:
Research Paper
Organization / Institution:
Not specified
Author:
Abigail Obuobi
Target Audience:
Researchers, Pharmaceutical Developers
Period of validity:
N/A
Date of approval:
N/A
Date of changes:
N/A
Year:
2023
Region / City:
Japan, Tsukuba
Theme:
Material Science, Superalloys
Document Type:
Research Article
Institution:
National Institute for Materials Science (NIMS)
Authors:
Toshio Osada, Makoto Osawa, Yuhi Mori, Ayako Ikeda, Hiroshi Harada, Takuma Kohata, Kyoko Kawagishi
Target Audience:
Researchers in material science and high-temperature superalloys
Period of validity:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2024
Region / City:
Miami, United States
Field:
Web Development, Security
Document Type:
Research Article
Institution:
Smart Barrel
Author:
Onwuegbuzie
Target Audience:
Developers, Policymakers
Period of Validity:
September 2024 - March 2025
Approval Date:
N/A
Date of Changes:
N/A
Year:
2023
Region / City:
Not specified
Topic:
Telehealth, Patient-Reported Outcomes
Document Type:
Research article
Institution:
Purdue University
Author:
Kaleb Emerson, Lyndsey N. Graham, Veronika Vozka, Riley Naughton, Katlyn Peek, Bridgette L. Kelleher
Target Audience:
Researchers, Healthcare Providers
Period of Action:
Ongoing (Project WellCAST)
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
Ghawar Oilfield, Saudi Arabia
Field of Study:
Oilfield Operations, Energy Optimization
Document Type:
Research Paper
Institution:
Saudi Aramco
Author:
Abdullah Alghazal
Target Audience:
Researchers, Energy Engineers, Oilfield Operators
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2025
Region / city:
International
Topic:
Taxonomy, Virology
Document type:
Proposal
Organ / institution:
International Committee on Taxonomy of Viruses (ICTV)
Author:
Caixia Yang, Avijit Roy, Juliana Freitas-Astúa, Antonio Tiberini, Li Jun-Min, Kavi Sidharthan, Mónica Madariaga-Villarroel, Sergey Y. Morozov, Pedro L. Ramos-González
Target audience:
Virologists, Taxonomists
Period of validity:
2025-2026
Approval date:
03/06/2025
Revision date:
20/08/2025
Year:
2026
Region / City:
N/A
Topic:
Cancer research, Immunotherapy
Document Type:
Research article
Organization / Institution:
N/A
Author:
Walid S. Kamoun, Anne-Sophie Dugast, James J. Suchy, Stephanie Grabow, Ross B. Fulton, James F. Sampson, Lia Luus, Michael Santiago, Alexander Koshkaryev, Gang Sun, Vasileios Askoxylakis, Eric Tam, Zhaohua Richard Huang, Daryl C. Drummond, Andrew J. Sawyer
Target Audience:
Researchers, Oncology professionals
Period of Action:
N/A
Approval Date:
N/A
Modification Date:
N/A